Proffitt JH - Search Results

1

Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions.

Lozanski G, Heerema NA, Flinn IW, Smith L, Harbison J, Webb J, Moran M, Lucas M, Lin T, Hackbarth ML, Proffitt JH, Lucas D, Grever MR, Byrd JC. Lozanski G, et al. Among authors: proffitt jh. Blood. 2004 May 1;103(9):3278-81. doi: 10.1182/blood-2003-10-3729. Epub 2004 Jan 15. Blood. 2004. PMID: 14726385 Free article.

2

Interphase cytogenetic abnormalities in chronic lymphocytic leukemia may predict response to rituximab.

Byrd JC, Smith L, Hackbarth ML, Flinn IW, Young D, Proffitt JH, Heerema NA. Byrd JC, et al. Among authors: proffitt jh. Cancer Res. 2003 Jan 1;63(1):36-8. Cancer Res. 2003. PMID: 12517774

3

A molecular cytogenetic analysis of 7q31 in prostate cancer.

Jenkins RB, Qian J, Lee HK, Huang H, Hirasawa K, Bostwick DG, Proffitt J, Wilber K, Lieber MM, Liu W, Smith DI. Jenkins RB, et al. Cancer Res. 1998 Feb 15;58(4):759-66. Cancer Res. 1998. PMID: 9485032

4

Prognostic value of genomic alterations in invasive cervical squamous cell carcinoma of clinical stage IB detected by comparative genomic hybridization.

Dellas A, Torhorst J, Jiang F, Proffitt J, Schultheiss E, Holzgreve W, Sauter G, Mihatsch MJ, Moch H. Dellas A, et al. Cancer Res. 1999 Jul 15;59(14):3475-9. Cancer Res. 1999. PMID: 10416613

5

Gene copy mapping of the ERBB2/TOP2A region in breast cancer.

Jacobson KK, Morrison LE, Henderson BT, Blondin BA, Wilber KA, Legator MS, O'Hare A, Van Stedum SC, Proffitt JH, Seelig SA, Coon JS. Jacobson KK, et al. Among authors: proffitt jh. Genes Chromosomes Cancer. 2004 May;40(1):19-31. doi: 10.1002/gcc.20019. Genes Chromosomes Cancer. 2004. PMID: 15034864

6

Diagnostic utility of fluorescence in situ hybridization in mantle-cell lymphoma.

Remstein ED, Kurtin PJ, Buño I, Bailey RJ, Proffitt J, Wyatt WA, Hanson CA, Dewald GW. Remstein ED, et al. Br J Haematol. 2000 Sep;110(4):856-62. doi: 10.1046/j.1365-2141.2000.02303.x. Br J Haematol. 2000. PMID: 11054068 Free article.

7

The role of fluorescence in situ hybridization technologies in molecular diagnostics and disease management.

King W, Proffitt J, Morrison L, Piper J, Lane D, Seelig S. King W, et al. Mol Diagn. 2000 Dec;5(4):309-19. doi: 10.1007/BF03262092. Mol Diagn. 2000. PMID: 11172495 Review.

8

Genetic transfer and expression of reconstructed yeast artificial chromosomes containing normal and translocated BCL2 proto-oncogenes.

Silverman GA, Yang E, Proffitt JH, Zutter M, Korsmeyer SJ. Silverman GA, et al. Among authors: proffitt jh. Mol Cell Biol. 1993 Sep;13(9):5469-78. doi: 10.1128/mcb.13.9.5469-5478.1993. Mol Cell Biol. 1993. PMID: 8355694 Free PMC article.

9

DNase I-hypersensitive sites in the galactose gene cluster of Saccharomyces cerevisiae.

Proffitt JH. Proffitt JH. Mol Cell Biol. 1985 Jun;5(6):1522-4. doi: 10.1128/mcb.5.6.1522-1524.1985. Mol Cell Biol. 1985. PMID: 3897838 Free PMC article.

10

5-Methylcytosine is not detectable in Saccharomyces cerevisiae DNA.

Proffitt JH, Davie JR, Swinton D, Hattman S. Proffitt JH, et al. Mol Cell Biol. 1984 May;4(5):985-8. doi: 10.1128/mcb.4.5.985-988.1984. Mol Cell Biol. 1984. PMID: 6374428 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters